Enhanced expression of WD repeat-containing protein 35 via nuclear factor-kappa B activation in bupivacaine-treated Neuro2a cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Huang, Lei ^a   Kondo, Fumio ^a   Harato, Misako ^a   Feng, Guo Gang ^a   Ishikawa, Naoshisa ^a   Fujiwara, Yoshihiro ^a   Okada, Shoshiro ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CELL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; WD REPEAT CONTAINING PROTEIN 35;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; WDR35 GENE;

ANIMALS; BUPIVACAINE; CELL LINE, TUMOR; GENE EXPRESSION; MICE; NF-KAPPA B; PROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1;

EID: 84907032632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086336     Document Type: Article

References (41)

1. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF (1994) The ancient regulatory-protein family of WD-repeat proteins. Nature 371: 297-300. (Pubitemid 24300613)
2. Smith TF, Gaitatzes C, Saxena K, Neer EJ (1999) The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 24: 181-185. (Pubitemid 29348450)
3. Feng GG, Li C, Huang L, Tsunekawa K, Sato Y, et al. (2010) Naofen, a novel WD40-repeat protein, mediates spontaneous and tumor necrosis factor-induced apoptosis. Biochem Biophys Res Commun 394: 153-157.
4. Sato Y, Feng GG, Huang L, Fan JH, Li C, et al. (2010) Enhanced expression of naofen in kidney of streptozotocin-induced diabetic rats: possible correlation to apoptosis of tubular epithelial cells. Clin Exp Nephrol 14: 205-212.
5. Fan JH, Feng GG, Huang L, Tsunekawa K, Honda T, et al. (2012) Role of naofen in apoptosis of hepatocytes induced by lipopolysaccharide through mitochondrial signaling in rats. Hepatol Res 42: 696-705.
6. Tsunekawa K, Kondo F, Okada T, Feng GG, Huang L, et al. (2013) Enhanced expression of WD repeat-containing protein 35 (WDR35) stimulated by domoic acid in rat hippocampus: involvement of reactive oxygen species generation and p38 mitogen-activated protein kinase activation. BMC Neurosci 14: 4.
7. Mill P, Lockhart PJ, Fitzpatrick E, Mountford HS, Hall EA, et al. (2011) Human and mouse mutations in WDR35 cause short-rib polydactyly syndromes due to abnormal ciliogenesis. Am J Hum Genet 88: 508-515.
8. Rahman I, Marwick J, Kirkham P (2004) Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68: 1255-1267. (Pubitemid 39094292)
9. Harper SJ, LoGrasso P (2001) Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 13: 299-310. (Pubitemid 32448947)
10. Perez-Castro R, Patel S, Garavito-Aguilar ZV, Rosenberg A, Recio-Pinto E, et al. (2009) Cytotoxicity of local anesthetics in human neuronal cells. Anesth Analg 108: 997-1007.
11. Park CJ, Park SA, Yoon TG, Lee SJ, Yum KW, et al. (2005) Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res 84: 852-857. (Pubitemid 43827820)
12. Lirk P, Haller I, Colvin HP, Lang L, Tomaselli B, et al. (2008) In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity. Anesth Analg 106: 1456-1464. (Pubitemid 351571076)
13. Lu J, Xu SY, Zhang QG, Xu R, Lei HY (2011) Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways. Eur J Pharmacol 657: 51-58.
14. Harato M, Huang L, Kondo F, Tsunekawa K, Feng GG, et al. (2012) Bupivacaine-induced apoptosis independently of WDR35 expression in mouse neuroblastoma Neuro2a cells. BMC Neurosci 13: 149.
15. Sen CK, Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720. (Pubitemid 26172817)
16. Hsu TC, Young MR, Cmarik J, Colburn NH (2000) Activator protein 1 (AP-1)-and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 28: 1338-1348. (Pubitemid 30621478)
17. Granado-Serrano AB, Martín MA, Haegeman G, Goya L, Bravo L, et al. (2010) Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylino-sitol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells. Br J Nutr 103: 168-179.
18. Kefaloyianni E, Gaitanaki C, Beis I (2006) ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 18: 2238-2251. (Pubitemid 44740489)
19. Salminen A, Kauppinen A, Kaarniranta K (2012) Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell Signal 24: 835-845.
20. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4: 131-136.
21. Chun KS, Kim SH, Song YS, Surh YJ (2004) Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis 25: 713-722.
22. Lepsch LB, Munhoz CD, Kawamoto EM, Yshii LM, Lima LS, et al. (2009) Cocaine induces cell death and activates the transcription nuclear factor kappa-B in PC12 cells. Mol Brain 2: 3.
23. Unami A, Shinohara Y, Ichikawa T, Baba Y (2003) Biochemical and microarray analyses of bupivacaine-induced apoptosis. J Toxicol Sci 28: 77-94. (Pubitemid 36764758)
24. Teng YN, Chuang PJ, Liu YW (2013) Nuclear Factor-κB (NF-κB) Regulates the Expression of Human Testis-Enriched Leucine-Rich Repeats and WD Repeat Domain Containing 1 (LRWD1) Gene. Int J Mol Sci 14: 625-639.
25. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, et al. (2004) NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 24: 7806-7819. (Pubitemid 39121503)
26. D'Acquisto F, Iuvone T, Rombolà L, Sautebin L, Di Rosa M, et al. (1997) Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 418: 175-178. (Pubitemid 27514441)
27. Nakajima K, Matsushita Y, Tohyama Y, Kohsaka S, Kurihara T (2006) Differential suppression of endotoxin-inducible inflammatory cytokines by nuclear factor kappa B (NFkappaB) inhibitor in rat microglia. Neurosci Lett 401: 199-202. (Pubitemid 43729524)
28. Akutsu M, Ogura N, Ito K, Kawashima M, Kishida T, et al. (2013) Effects of interleukin-1b and tumor necrosis factor-a on macrophage inflammatory protein-3a production in synovial fibroblast-like cells from human temporomandibular joints. J Oral Pathol Med 42: 491-498.
29. Ricote M, Glass CK (2007) PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771: 926-935. (Pubitemid 47198544)
30. Chen YC, Wu JS, Tsai HD, Huang CY, Chen JJ, et al. (2012) Peroxisome proliferator-activated receptor gamma (PPAR-c) and neurodegenerative disorders. Mol Neurobiol 46: 114-124.
31. Fakhfouri G, Ahmadiani A, Rahimian R, Grolla AA, Moradi F, et al. (2012) WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-c pathway. Neuropharmacology 63: 653-666.
32. Liu ZJ, Liu W, Liu L, Xiao C, Wang Y, et al. (2013) Curcumin Protects Neuron against Cerebral Ischemia-Induced Inflammation through Improving PPARGamma Function. Evid Based Complement Alternat Med 2013: 470975.
33. Kundu JK, Shin YK, Surh YJ (2006) Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem Pharmacol 72: 1506-1515. (Pubitemid 44666749)
34. Meng Q, Xia Y (2011) c-Jun, at the crossroad of the signaling network. Protein Cell 2: 889-898.
35. Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M (1991) Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494-496. (Pubitemid 21896867)
36. Berisha SZ, Serre D, Schauer P, Kashyap SR, Smith JD (2011) Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study. PLoS One 6: e16729.
37. Nordlund J, Milani L, Lundmark A, Lönnerholm G, Syvänen AC (2012) DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission. PLoS One 7: e34513.
38. Lu X, Wang L, Chen S, He L, Yang X, et al. (2012) Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet 44: 890-894.
39. Bacino CA, Dhar SU, Brunetti-Pierri N, Lee B, Bonnen PE (2012) WDR35 mutation in siblings with Sensenbrenner syndrome: a ciliopathy with variable phenotype. Am J Med Genet A 158A: 2917-2924.
40. Wang YY, Liu LJ, Zhong B, Liu TT, Li Y, et al. (2010) WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-kappaB activation. Proc Natl Acad Sci U S A 107: 815-820.
41. Sun Z, Smrcka AV, Chen S (2013) WDR26 functions as a scaffolding protein to promote Gβγ-mediated phospholipase C β2 (PLCβ2) activation in leukocytes. J Biol Chem 288: 16715-16725.